LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Pipeline
Deals
Financings
Articles
Atomwise Inc.
Headquarters:
San Francisco, CA, United States
Website:
http://www.atomwise.com
Year Founded:
2012
Status:
Private
BioCentury
|
Feb 20, 2025
Management Tracks
Bourla becomes chair of PhRMA
Plus: Steve Worland named CEO of Atomwise and updates from Ona, Cidara and Biosion
Read More
BioCentury
|
Oct 3, 2023
Management Tracks
Affibody names Peter Zerhouni CFO
Plus: Restructuring at Kezar as CEO, CMO step down, and updates from Atomwise, Aura, Twist, Acelyrin and more
Read More
BioCentury
|
Sep 27, 2023
Deals
Insilico’s evolving AI deals: from ‘death by pilot’ to $80M up front
The AI company’s Exelixis partnership highlights its strategic pivots in a shifting landscape
Read More
BioCentury
|
Sep 25, 2023
Product Development
Instilling AI and scaling Dupixent: two pillars of Hudson’s strategy at Sanofi
A conversation with Sanofi CEO Paul Hudson
Read More
BioCentury
|
Jul 31, 2023
Product Development
In Sanofi’s digital revolution, software product development is the common tongue
Everyone should understand how digital solutions to employee pain points get built, says Sanofi’s head of digital for R&D
Read More
BioCentury
|
Nov 9, 2022
Regulation
Nov. 8 Quick Takes: FDA request could extend review of BioMarin’s hemophilia therapy
Plus Sanofi’s latest AI deal taps Insilico and updates from Kronos, Marinus and more
Read More
BioCentury
|
Sep 14, 2022
Management Tracks
AZ and Novartis veteran Tommasi to lead R&D at Dunad
Plus new CSOs at Atomwise and Sotio, and updates from Nine Square, Fabric and Biolojic Design
Read More
BioCentury
|
Feb 16, 2022
Discovery & Translation
Bridge Bio goes early with next-gen chemoproteomics
The Korean biotech’s collaboration with Vividion co-founders at Scripps will explore reactive chemistries beyond cysteine
Read More
BioCentury
|
Jan 26, 2022
Management Tracks
FDA’s Sipes leaving CDER for White House
Plus Ortiz joins Telix as COO, and updates from Chinook, Atomwise and more
Read More
BioCentury
|
Sep 22, 2021
Product Development
Unpartnered KRAS programs: Data Byte
Companies looking to in-license KRAS inhibitors may need to go early stage
Read More
Items per page:
10
1 - 10 of 38